Dako AS-医療機器分野:企業M&A・提携分析

◆英語タイトル:Dako AS - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011013
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dako A/S (Dako Denmark), a subsidiary of Agilent Technologies Inc is a diagnostic company. The company’s products include diagnostic antibodies, reagents and kits, software related products, instruments and related products, clone products, and synonym products. It also provides immunohistochemistry products, pharmacodiagnostic products, molecular pathology products, special stain products, flow cytometry products, specific proteins, custom made antibodies, labeled probes and detection systems, special stains kits, and ISH ancillaries and accessories, among others. Dako Denmark offers services such as pre treatment solutions, deployment and instrument services, application and technical support, instrument service agreements, safety data sheets, protocol updates, instrument manuals, and application notes for turbidimetry. The company serves hospitals and research laboratories. It operates in Denmark and the US. Dako Denmark is headquartered in Glostrup, Denmark.

Dako AS – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Dako A/S, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Dako A/S, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Dako A/S, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Dako A/S, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Dako A/S, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Dako A/S, Medical Equipment, Deal Details 10
Asset Purchase 10
Dako To Acquire Intellectual Property Rights From System Dynamics 10
Partnerships 11
Dako Enters Into Licensing Agreement With Van Andel Research Institute For Cancer Diagnostic Tool 11
Merck and Pfizer Enters into Agreement with Dako 12
Dako Enters into Co-Development Agreement with Amgen for Companion Diagnostic 13
Dako Enters into Development Agreement with ONO PHARMA for Opdivo 14
Dako Enters into Agreement with Merck for Companion Diagnostic Test 15
Dako Enters Into Co-Development Agreement With Amgen For Molecular Diagnostic Test 16
Dako And Omnyx Enter Into Co-Marketing Agreement For Breast Cancer Diagnostics 17
Dako Enters Into Agreement With Pfizer For Companion Diagnostics 18
Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests 19
Dako Enters Into Co-Development Agreement With Amgen 20
Dako Enters Into Co-Development Agreement With Amgen 21
Dako Enters Into Co-Development Agreement With Bristol-Myers 22
Dako Denmark Enters Into Co-Development Agreement With Epitomics 23
Acquisition 24
Leica Biosystems Completes Acquisition Of Aperio Technologies 24
Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion 26
Dako A/S – Key Competitors 28
Dako A/S – Locations And Subsidiaries 28
Head Office 28
Recent Developments 29
Product News 29
Oct 17, 2017: BluePrint Phase 2 Demonstrates Digital Pathology Review Equivalent to Glass Slides 29
May 05, 2016: Preliminary results comparing PD-L1 IHC diagnostic assays in lung cancer released 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Dako A/S, Medical Equipment, Key Facts 2
Dako A/S, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Dako A/S, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Dako A/S, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Dako A/S, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Dako A/S, Deals By Market, 2011 to YTD 2017 8
Dako A/S, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Dako To Acquire Intellectual Property Rights From System Dynamics 10
Dako Enters Into Licensing Agreement With Van Andel Research Institute For Cancer Diagnostic Tool 11
Merck and Pfizer Enters into Agreement with Dako 12
Dako Enters into Co-Development Agreement with Amgen for Companion Diagnostic 13
Dako Enters into Development Agreement with ONO PHARMA for Opdivo 14
Dako Enters into Agreement with Merck for Companion Diagnostic Test 15
Dako Enters Into Co-Development Agreement With Amgen For Molecular Diagnostic Test 16
Dako And Omnyx Enter Into Co-Marketing Agreement For Breast Cancer Diagnostics 17
Dako Enters Into Agreement With Pfizer For Companion Diagnostics 18
Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests 19
Dako Enters Into Co-Development Agreement With Amgen 20
Dako Enters Into Co-Development Agreement With Amgen 21
Dako Enters Into Co-Development Agreement With Bristol-Myers 22
Dako Denmark Enters Into Co-Development Agreement With Epitomics 23
Leica Biosystems Completes Acquisition Of Aperio Technologies 24
Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion 26
Dako A/S, Key Competitors 28

★海外企業調査レポート[Dako AS-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kootenai Electric Cooperative Inc:企業の戦略的SWOT分析
    Kootenai Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Superior Industries International, Inc.:企業の戦略・SWOT・財務情報
    Superior Industries International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Superior Industries International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • AS Eesti Gaas:企業の戦略的SWOT分析
    AS Eesti Gaas - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Ashok Leyland Limited:企業の戦略・SWOT・財務情報
    Ashok Leyland Limited - Strategy, SWOT and Corporate Finance Report Summary Ashok Leyland Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Banco Popular Espanol, S.A.:企業のM&A・事業提携・投資動向
    Banco Popular Espanol, S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco Popular Espanol, S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • TESCO Personal Finance Group Ltd:企業の戦略・SWOT・財務情報
    TESCO Personal Finance Group Ltd - Strategy, SWOT and Corporate Finance Report Summary TESCO Personal Finance Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Sime Darby Unimills B.V. :企業の戦略・SWOT・財務情報
    Sime Darby Unimills B.V. - Strategy, SWOT and Corporate Finance Report Summary Sime Darby Unimills B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Asiana Airlines Inc.
    Asiana Airlines Inc. - Strategy, SWOT and Corporate Finance Report Summary Asiana Airlines Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Theranexus SAS (ALTHX):製薬・医療:M&Aディール及び事業提携情報
    Summary Theranexus SAS (Theranexus) is a biotechnology company that discovers and develops drug combinations for safe and efficient neurological and psychiatric treatments. The company develops THN102, a pipeline product that comprises modafinil. It also offers THN02 for the treatment of sleepiness …
  • Valecha Engineering Ltd:戦略・SWOT・企業財務分析
    Valecha Engineering Ltd - Strategy, SWOT and Corporate Finance Report Summary Valecha Engineering Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • SKF AB:企業の戦略・SWOT・財務分析
    SKF AB - Strategy, SWOT and Corporate Finance Report Summary SKF AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • NiSource Inc.:企業の戦略・SWOT・財務分析
    NiSource Inc. - Strategy, SWOT and Corporate Finance Report Summary NiSource Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Waste Management Inc (WM):企業の財務・戦略的SWOT分析
    Waste Management Inc (WM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Kimal plc-医療機器分野:企業M&A・提携分析
    Summary Kimal plc (Kimal) is a medical equipment company that develops, manufactures and markets customised procedure packs and vascular access devices. The company’s products include soft tissue biopsy needles, bone marrow biopsy needles, catheter accessories, catheter lock solution, closure device …
  • Opthea Ltd (OPT)-製薬・医療分野:企業M&A・提携分析
    Summary Opthea Ltd (Opthea), formerly Circadian Technologies Ltd is a provider of research and development of angiogenesis and vascular leakage-based treatments for cancer focusing on vascular endothelial growth factors. The company’s pipeline products comprise VEGF-C, VEGF-D and VEGFR-3. Opthea’s d …
  • Mendor Oy-医療機器分野:企業M&A・提携分析
    Summary Mendor Oy (Mendor) is a medical equipment company that designs, develops and markets advanced diabetes management products. The company’s products include portable blood glucose meter and web-based software application for the daily management of diabetes. It offers blood glucose meter mendo …
  • Dialog Group Bhd (DIALOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Dialog Group Bhd (Dialog) is an oil and gas services company that offers integrated technical services. The company provides technical services for logistics and upstream assets; engineering, procurement, construction, and commissioning; plant maintenance and catalyst handling; fabrication; …
  • OGK-2 (OGKB):企業の財務・戦略的SWOT分析
    OGK-2 (OGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Mosaic Brands Ltd (MOZ):企業の財務・戦略的SWOT分析
    Mosaic Brands Ltd (MOZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Mercer LLC:企業の戦略的SWOT分析
    Mercer LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆